Anavex Life Sciences Corp (AVXL)

[georgejjl]

Tuesday February 11, 2020 at BIO CEO & Investor Conference

3:00 PM - 3:55 PM
Tuesday, February 11
Neuroscience at the Crossroads: Late Stage Brain Disorder Pipelines and Unmet Needs

https://www.bio.org/events/bio-ceo-investor-conference/speakers/894498

Dr. Christopher U. Missling, PhD

PRESIDENT AND CEO, ANAVEX LIFE SCIENCES CORP.
New York, New York, United States
Christopher U. Missling, PhD is President and CEO of Anavex Life Sciences Corp, has over 20 years of healthcare industry experience within large pharmaceutical companies and the biotech industry. Prior to joining Anavex, he served as the Chief Financial Officer of Curis and ImmunoGen. In addition, at Aventis (now Sanofi), Christopher’s work is dedicated to finding potential cures for neurodegenerative and neurodevelopmental diseases, like Alzheimer’s disease, and Parkinson’s disease, as well as, Rett syndrome, Fragile X, Angelman’s syndrome, infantile spasms. Dr. Missling is working with his team to advance new potential treatments through clinical trials by involving the respective advocacy groups early on. Dr. Missling has an MS and PhD from the University of Munich in Chemistry and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management.

Speaking In
3:00 PM - 3:55 PM
Tuesday, February 11
Neuroscience at the Crossroads: Late Stage Brain Disorder Pipelines and Unmet Needs

https://www.bio.org/events/bio-ceo-investor-conference/speakers/894498

Good luck and GOD bless,